在与GBA相关的帕金森病中解开自主功能障碍
Grazia Devigili1, Giulia Straccia1,2, Emanuele Cereda3
1Fondazione IRCCS Istituto Neurologico Carlo Besta, Department of Clinical Neurosciences, Parkinson and Movement Disorders Unit, Milan, Italy.
Movement disorders clinical practice
|November 29, 2023
概括
患有帕金森病 (PD) 和GBA基因突变 (GBA-PD) 的患者表现出显著的自主功能障碍,包括心血管和运动障碍. 仪器评估对于检测这些异常至关重要,这些异常往往仅通过临床测量而被低估.
科学领域:
- 神经学 神经学
- 遗传学 是一个遗传学.
- 自主神经科学 自主神经科学
背景情况:
- 患有帕金森病 (PD) 和GBA基因突变 (GBA-PD) 的患者比非携带者体验更多的非运动并发症.
- 之前的研究缺乏使用广泛措施对GBA-PD中心血管和运动自主功能障碍的客观表征.
- 在GBA-PD中降低的生存率表明,除了年龄和痴呆症之外,还存在未被识别的促成因素.
研究的目的:
- 用仪器测量GBA-PD中自主功能障碍的模式和严重程度.
- 探索GBA-PD中自主功能障碍和其他非运动症状之间的相关性.
- 确定GBA-PD中自主功能障碍的临床影响.
主要方法:
- 包括21名GBA-PD患者和24名匹配的PD非携带者在内的横截面研究.
- 运动和非运动特征的全面评估,包括神经心理测试.
- 通过R-R间隔和血压变化分析评估心血管自主功能,并通过动态汗水测试评估血流运动功能.
主要成果:
- 与非携带者相比,GBA-PD患者在心血管,交感和运动功能方面表现出更严重的损伤,尽管临床症状最小.
- 结果表明,在GBA-PD中,显著的心脏交 - 阴道调节,高效的巴罗反射失效和外周交功能障碍.
- 心血管功能失调症在GBA-PD中只显示了与认知障碍的边际相关性.
结论:
- 与PD非载体患者相比,GBA-PD患者表现出更严重的仪器自主性异常.
- 临床测量可能会低估GBA-PD中自主功能障碍的程度.
- 建议对所有GBA-PD患者进行仪器自主评估,不论表现出什么症状.
相关概念视频
01:15Parkinson's Disease: Overview
557
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
557
01:24Parkinson's Disease: Treatment
276
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
276
01:37Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
01:18Disorders of the Autonomic Nervous System
657
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
Raynaud's disease, also known as Raynaud's...
657
01:28Drugs Acting on Autonomic Ganglia: Blockers
1.0K
Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
1.0K
01:20Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K